There is a theoretical possibility that hsa-miR-181d-5p may regulate CDKN3 expression through the AKT signaling pathway, thereby potentially influencing the progression of non-small cell lung carcinoma. This evidence concerns the gene CDKN3 and non-small cell lung carcinoma.